Creative Planning
LEGN icon

Creative Planning’s Legend Biotech LEGN Stock Holding History

Creative Planning’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$995K Buy
55,017
+37,136
+208% +$708K ﹤0.01% 2461
2025
Q4 		$389K Sell
17,881
-27,426
-61% -$786K ﹤0.01% 3047
2025
Q3 		$1.48M Buy
45,307
+1,999
+5% +$73.8K ﹤0.01% 1774
2025
Q2 		$1.54M Buy
43,308
+30,354
+234% +$984K ﹤0.01% 1523
2025
Q1 		$440K Sell
12,954
-2,986
-19% -$107K ﹤0.01% 2404
2024
Q4 		$519K Buy
+15,940
New +$660K ﹤0.01% 2185

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
FBIL
First Beijing Investment Ltd Hong Kong $2.32B AUM 8.06% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Creative Planning's LEGN Position: Q1 2026 in Review

Creative Planning increased its Legend Biotech (LEGN) stake by 208% in Q1 2026, buying an estimated $708K and bringing the position to 55,017 shares worth $995K. The position accounts for ﹤0.01% of the portfolio, ranked #2461.

Creative Planning first reported a position in LEGN in Q4 2024 and has held it in 6 quarters since. The position peaked at $1.54M in Q2 2025. 189 funds tracked by Wall St. Rank hold LEGN as of Q1 2026.

  • Creative Planning held 55,017 shares of Legend Biotech worth $995K as of Q1 2026.
  • Creative Planning bought 37,136 Legend Biotech shares in Q1 2026, an estimated $708K.
  • Legend Biotech made up ﹤0.01% of Creative Planning's portfolio in Q1 2026, its #2461 holding.
  • Creative Planning first reported a position in Legend Biotech in Q4 2024 and has held it in 6 quarters since.
  • Creative Planning's Legend Biotech position peaked at $1.54M in Q2 2025.
  • 189 funds tracked by Wall St. Rank held Legend Biotech as of Q1 2026.

Based on Creative Planning's 13F filing for Q1 2026, filed 12 May 2026.